Ultrasound scanning is an accurate and objective method to assess thyroid volume; therefore it is useful to evaluate the effectiveness of
L-thyroxine treatment in reducing
goiter size, especially in children where clinical evaluation is inaccurate. In this prospectic study we evaluated the effectiveness of one-year
L-thyroxine treatment in a group of children with nontoxic diffuse
goiter coming from an area with low
iodine intake. We examined 11 children (7 females, 4 males), age range 9-14 years. At clinical examination, 6 patients had a
goiter classified Ia (according to WHO criteria), 4 had a class Ib and only 1 had a class II
goiter. In order to achieve an accurate
goiter evaluation, the thyroid volume was determined by ultrasonic scanning with a 5 MHz linear probe before and
after treatment. Patients were given a dose of
L-thyroxine (1.5-2.0 micrograms/kg/die) in order to significantly reduce serum TSH levels (from 1.8 +/- 0.6 to 0.8 +/- 0.5 mU/l, mean +/- SD). Patients were reexamined at 12 months of
therapy and again
at 10 months after
therapy withdrawal. A significant reduction of the
goiter volume (greater than 20%) was obtained in 6/11 (54%) patients, although serum TSH levels were fully suppressed only in one. The mean
goiter size reduction in "responders" was -31.2 +/- 9.3% (m +/- SE). After
therapy withdrawal
goiter size increased in the majority of cases (in 4/11, greater than 20%). Our study demonstrates that
L-thyroxine treatment is effective in reducing
goiter size in the majority of children with a diffuse
goiter.(ABSTRACT TRUNCATED AT 250 WORDS)